206 related articles for article (PubMed ID: 10396127)
1. The 5-HT1A receptor and its ligands: structure and function.
Olivier B; Soudijn W; van Wijngaarden I
Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice.
Cao BJ; Rodgers RJ
Psychopharmacology (Berl); 1998 Oct; 139(3):185-94. PubMed ID: 9784072
[TBL] [Abstract][Full Text] [Related]
3. A synthetic overview of new molecules with 5-HT1A binding affinities.
Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
[TBL] [Abstract][Full Text] [Related]
4. Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.
Fletcher A; Cliffe IA; Dourish CT
Trends Pharmacol Sci; 1993 Dec; 14(12):41-8. PubMed ID: 8122313
[TBL] [Abstract][Full Text] [Related]
5. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors.
Sabb AL; Vogel RL; Kelly MG; Palmer Y; Smith DL; Andree TH; Schechter LE
Bioorg Med Chem Lett; 2001 Apr; 11(8):1069-71. PubMed ID: 11327592
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands.
Paluchowska MH; Dereń-Wesołek A; Mokrosz JL; Charakchieva-Minol S; Chojnacka-Wójcik E
Arch Pharm (Weinheim); 1996 Oct; 329(10):451-6. PubMed ID: 8933747
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for 5-HT1A agonists in the treatment of depression?
Blier P; Ward NM
Biol Psychiatry; 2003 Feb; 53(3):193-203. PubMed ID: 12559651
[TBL] [Abstract][Full Text] [Related]
9. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
10. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
[TBL] [Abstract][Full Text] [Related]
11. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
Kuipers W; Van Wijngaarden I; Ijzerman AP
Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638
[TBL] [Abstract][Full Text] [Related]
12. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
13. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
Wesołowska A; Jastrzębska-Więsek M
Int Rev Neurobiol; 2011; 96():49-71. PubMed ID: 21329784
[No Abstract] [Full Text] [Related]
14. Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data.
Wesołowska A
Pharmacol Rep; 2010; 62(4):564-77. PubMed ID: 20884998
[TBL] [Abstract][Full Text] [Related]
15. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
16. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
Pranzatelli MR
Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
[TBL] [Abstract][Full Text] [Related]
17. Ligand-5-HT1A receptor interaction.
Chilmonczyk Z
Farmaco; 2000 Mar; 55(3):191-3. PubMed ID: 10919079
[TBL] [Abstract][Full Text] [Related]
18. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
19. Involvement of 5-HT1A receptors in the consolidation of learning in cognitively impaired rats.
Meneses A; Terrón JA; Hong E
Ann N Y Acad Sci; 1998 Dec; 861():286-7. PubMed ID: 9928294
[No Abstract] [Full Text] [Related]
20. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants.
Levy AD; Van de Kar LD
Life Sci; 1992; 51(2):83-94. PubMed ID: 1352027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
